Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child

Maartje Blom; Ingrid Pico-Knijnenburg; Joris M. van Montfrans; Robbert G.M. Bredius; Mirjam van der Burg; Jesse J. Swen; Dagmar Berghuis

doi:10.1007/s10875-021-01138-9

Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child

Maartje Blom
, Ingrid Pico-Knijnenburg
, Joris M. van Montfrans
, Robbert G.M. Bredius
, Mirjam van der Burg
, Jesse J. Swen
, Dagmar Berghuis^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	199-202
Number of pages	4
Journal	Journal of Clinical Immunology
Volume	42
Issue number	1
DOIs	https://doi.org/10.1007/s10875-021-01138-9
Publication status	Published - 7 Oct 2021

Access to Document

10.1007/s10875-021-01138-9

Blom2022_Article_AbnormalResultsOfNewbornScreenFinal published version, 746 KBLicence: Taverne

Cite this

@article{453843ae616249f789ed46201d8ebf19,

title = "Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child",

author = "Maartje Blom and Ingrid Pico-Knijnenburg and \{van Montfrans\}, \{Joris M.\} and Bredius, \{Robbert G.M.\} and \{van der Burg\}, Mirjam and Swen, \{Jesse J.\} and Dagmar Berghuis",

note = "Funding Information: The authors would like to thank all those involved in the SONNET-study for their contribution to the study. A special thanks to all parents of the cases?and dr. S.M.H. Timmermans for their participation and support.",

year = "2021",

month = oct,

day = "7",

doi = "10.1007/s10875-021-01138-9",

language = "English",

volume = "42",

pages = "199--202",

journal = "Journal of Clinical Immunology",

issn = "0271-9142",

publisher = "Springer",

number = "1",

}

Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child. / Blom, Maartje; Pico-Knijnenburg, Ingrid; van Montfrans, Joris M. et al.
In: Journal of Clinical Immunology, Vol. 42, No. 1, 07.10.2021, p. 199-202.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero

T2 - Benefit of TPMT Genotyping in Both Mother and Child

AU - Blom, Maartje

AU - Pico-Knijnenburg, Ingrid

AU - van Montfrans, Joris M.

AU - Bredius, Robbert G.M.

AU - van der Burg, Mirjam

AU - Swen, Jesse J.

AU - Berghuis, Dagmar

N1 - Funding Information: The authors would like to thank all those involved in the SONNET-study for their contribution to the study. A special thanks to all parents of the cases?and dr. S.M.H. Timmermans for their participation and support.

PY - 2021/10/7

Y1 - 2021/10/7

UR - https://www.scopus.com/pages/publications/85116541565

U2 - 10.1007/s10875-021-01138-9

DO - 10.1007/s10875-021-01138-9

M3 - Comment/Letter to the editor

AN - SCOPUS:85116541565

SN - 0271-9142

VL - 42

SP - 199

EP - 202

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

IS - 1

ER -

Abnormal Results of Newborn Screening for SCID After Azathioprine Exposure In Utero: Benefit of TPMT Genotyping in Both Mother and Child

Access to Document

Other files and links

Cite this